Abstract:African swine fever (ASF) is a highly fatal viral disease that poses a significant threat to domestic pigs and wild boars globally. In our study, we aimed to explore the potential of a multiplexed CRISPR-Cas system in suppressing ASFV replication and infection. By engineering CRISPR-Cas systems to target nine specific loci within the ASFV genome, we observed a substantial reduction in viral replication in vitro. This reduction was achieved through the concerted action of both Type II and Type III RNA polymerase-guided gRNA expression. To further evaluate its anti-viral function in vivo, we developed a pig strain expressing the multiplexable CRISPR-Cas-gRNA via germline genome editing. These transgenic pigs exhibited normal health with continuous expression of the CRISPR-Cas-gRNA system, and a subset displayed latent viral replication and delayed infection. However, the CRISPR-Cas9-engineered pigs did not exhibit a survival advantage upon exposure to ASFV. To our knowledge, this study represents the first instance of a living organism engineered via germline editing to assess resistance to ASFV infection using a CRISPR-Cas system. Our findings contribute valuable insights to guide the future design of enhanced viral immunity strategies. Importance: ASFV is currently a devastating disease with no effective vaccine or treatment available. Our study introduces a multiplexed CRISPR-Cas system targeting nine specific loci in the ASFV genome. This innovative approach successfully inhibits ASFV replication in vitro, and we have successfully engineered pig strains to express this anti-ASFV CRISPR-Cas system constitutively. Despite not observing survival advantages in these transgenic pigs upon ASFV challenges, we did note a delay in infection in some cases. To the best of our knowledge, this study constitutes the first example of a germline-edited animal with an anti-virus CRISPR-Cas system. These findings contribute to the advancement of future anti-viral strategies and the optimization of viral immunity technologies.

Differentiation of Classical Swine Fever Virus Virulent and Vaccine Strains by CRISPR/Cas13a

Safety, efficacy, and DIVA feasibility on a novel live attenuated classical swine fever marker vaccine candidate

Efficacy Evaluation of the C-strain-based Vaccines Against the Subgenotype 2.1d Classical Swine Fever Virus Emerging in China

COMPARISON AND APPLICATION OF SYBR GREEN AND TAQMAN BASED REAL-TIME PCR ASSAYS FOR DETECTION OF CLASSICAL SWINE FEVER VIRUS

Construction of a Chimeric Classical Swine Fever Virus C-strain Containing E2 of Group Ⅱ Isolate Remains and Its Biological Characteristics

Continuous Passaging of A Recombinant C-Strain Virus in Pk-15 Cells Selects Culture-Adapted Variants That Showed Enhanced Replication but Failed to Induce Fever in Rabbits

Genetic Characterization of E2 Gene of Classical Swine Fever Virus by Restriction Fragment Length Polymorphism and Phylogenetic Analysis.

Identification of E2 Strain with Improved Secretion and Immunogenicity Against CSFV in Piglets

Research Progress and Challenges in Vaccine Development Against Classical Swine Fever Virus

Establishment and Application of Single and Duplex RT-PCR Method for Differentiation of Wild-type and Vaccine Viruses of Classical Swine Fever Virus

Generation of PCBP1-deficient pigs using CRISPR/Cas9-mediated gene editing

The Development of Classical Swine Fever Marker Vaccines in Recent Years

Genetically modified pigs are protected from classical swine fever virus

Differentiation of Virulent Shimen and Vaccine C Strains of Classical Swine Fever Virus by Duplex Reverse-Transcription Polymerase Chain Reaction

Development of Real-time RT-PCR using MGB Fluorescence Probe for Differentiation of Wild-type and Vaccine Strains of Classical Swine Fever Virus

Efficiency Comparison of a Novel E2 Subunit Vaccine and a Classic C-Strain Vaccine against Classical Swine Fever

Progress on Molecular Biology and Diagnostic Technique of Classical Swine Fever Virus

Differential Detection of Wild-Type and C-strain Vaccine Viruses of Classical Swine Fever Virus by SYBR Green Ⅰ Real-Time RT-PCR

Testing multiplexed anti-ASFV CRISPR-Cas9 in reducing African swine fever virus

Development of RT-PCR for Detection and Differentiation of Wild-Type and Vaccine Viruses of Classical Swine Fever Virus

A Reverse Transcription-Multiplex Nested Polymerase Chain Reaction for Detection and Differentiation of Wild-type and Vaccine Viruses of Classical Swine Fever Virus